Abstract
Platelet (PLT) support is critical to the care of patients with thrombocytopenia, but allogeneic transfusions carry risk. Pathogen reduction mitigates some transfusion risks, but effects on PLT function remain a concern. This clinical pilot study assessed the effect of pathogen reduction technology with riboflavin plus ultraviolet light using thrombelastography (TEG).
Originalsprog | Engelsk |
---|---|
Tidsskrift | Transfusion |
Vol/bind | 53 |
Udgave nummer | 9 |
Sider (fra-til) | 2043-52 |
Antal sider | 10 |
ISSN | 0041-1132 |
DOI | |
Status | Udgivet - sep. 2013 |